Lindbrook Capital, LLC Ac Immune Sa Transaction History

Lindbrook Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$4.83 - $7.56 $0 - $0	0 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$6.2 - $8.34 $0 - $0	0 New	0 $0
Q1 2020 Apr 22, 2020	SELL	$4.24 - $9.89 $2,120 - $4,945	-500 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$4.56 - $8.78 $2,280 - $4,390	500 New	500 $4,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.